Le Lézard
Classified in: Health
Subjects: NPT, LEG

Blue Cross Blue Shield of Massachusetts Releases Statement on Repeal of The Affordable Care Act's Individual Mandate


BOSTON, Dec. 2, 2017 /PRNewswire-USNewswire/ -- In response to the passage of Senate tax reform legislation which includes repeal of the Affordable Care Act's individual mandate, Andrew Dreyfus, President & CEO of Blue Cross Blue Shield of Massachusetts, released the following statement:

"The individual mandate has been an essential underpinning of health reform access and affordability, since it assures a balanced risk pool in order to prevent premium increases. A shared responsibility model is the best way to create the largest possible pool of insured so that the financial risk of coverage can be spread among both healthy and sick individuals. This approach has worked with other types of insurance and it has worked in Massachusetts, which has the lowest uninsured rate in the nation. The individual mandate is an important component of the ACA. To simply repeal it without any thought to an alternative, in the context of the tax bill, is not sound policy.

Blue Cross Blue Shield of Massachusetts logo

As senators from both parties have argued, we need a full policy debate over issues of this magnitude. Instead of using the tax bill to start dismantling the ACA, Congress should work in a bipartisan spirit to improve the ACA and create a health care system that is high-quality, affordable and sustainable."

About Blue Cross Blue Shield of Massachusetts

Blue Cross Blue Shield of Massachusetts (bluecrossma.com) is a community-focused, tax-paying, not?for?profit health plan headquartered in Boston. We're the trusted health plan for more than 25,000 Massachusetts employers and are committed to working with others in a spirit of shared responsibility to make quality health care affordable. Consistent with our corporate promise to always put our 2.8 million members first, we're rated among the nation's best health plans for member satisfaction and quality. Connect with us on FacebookTwitterYouTube, and LinkedIn.

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 07:05
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying...

at 07:00
Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo® (nivolumab) in combination with cisplatin and gemcitabine for the...

at 07:00
R&D Leader and software architect with more than three decades of experience designing, developing,...

at 07:00
Gordian Biotechnology, an in vivo drug discovery and development...

at 07:00
GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) & Risk Adjustment Solutions for Healthcare Providers and Payers, announced the acquisition of CCD Health, a...

at 07:00
Many American children...



News published on and distributed by: